Issue link: https://www.e-digitaleditions.com/i/1073928
A technical articles discusses defining the dosage strength for labeling of DPIs and a Point of View article makes recommendations to a young scientist to pursue inhalation research. February 2019 Volume 13 Number 1 Inhalation Inhalation (ISSN 1937-0717 print; ISSN 1940-414X online) is published six times per year in February, April, June, August, October and December by CSC Publishing, Inc., 1155 Northland Drive, Saint Paul, MN 55120. w w w . i n h a l a t i o n m a g . c o m Cover image shows the Kinaero™ High-Throughput Fire Down System, which automates the fire down process of pMDI devices for through-life testing, from Proveris Scientific Corporation, Two Cabot Road, Hudson, MA 01749, US, Tel.: +1 508 460- 8822, www.proveris.com product development/contract testing 7 Defining the dosage strength for labeling of DPIs: Use, limitations and relevance of in vitro data Jagdeep Shur, Robert Price, Tim Rouse, David Lewis, Dilraj Singh, Bradley Morrical and Stephen Edge 14 Issue focus: Product development/Contract testing formulation development/excipients 16 Special section: Formulation development/Excipients additional features 4 Cross-industry organizations: IPAC-RS: An update on recent activities 17 Point of View: Recommendations to a young scientist to pursue inhalation research Igor Gonda 24 Back Page: US FDA approves over-the-counter, non-CFC-based Primatene ® Mist; Patient advocacy groups object meetings 6 Previewing the Inhalation & Respiratory Drug Delivery USA Congress 22 A preview of Respiratory Drug Delivery (RDD ® ) Europe 2019 departments 3 Industry news 22 Respiratory medicine news Cover 3 Calendar Cover 3 White papers